Skip to main content
SpringerLink
Log in

Axillary Surgery

  • Chapter
  • First Online:
Oncoplastic and Reconstructive Breast Surgery

  • 1409 Accesses

Abstract

Randomized clinical trials have brought about major changes in the surgical management of the axilla in patients with breast cancer. Sentinel lymph node biopsy is the standard of care for axillary staging in patients with invasive breast carcinoma with clinically negative lymph nodes. Prior to the results of the ACOSOG Z0011 trial, all patients with a sentinel lymph node with metastasis underwent axillary lymph node dissection (ALND). The ACOSOG Z0011 trial demonstrated that women with clinically T1–T2 N0 disease who undergo breast-conserving surgery and whole-breast radiotherapy can safely avoid ALND. We review the main indications, contraindications, and controversies of SLNB in breast cancer as well as the results of the major recently clinical trials on managing the axilla in a patient with a clinically positive sentinel lymph node.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fisher B, Jeong H, Anderson S et al (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8):567–575

    Google Scholar 

  2. Sanghani M, Balk EM, Cady B (2009) Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and a meta-analysis. Cancer 115(8):1613–1620

    PubMed  Google Scholar 

  3. McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer five years after sentinel lymph node biopsy or axillary lymph node dissection: objective measurements. J Clin Oncol 26(32):5213–5219

    PubMed  PubMed Central  Google Scholar 

  4. Schijven MP, Vingerhoets AJ, Rutten HJ et al (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29(4):341–350

    CAS  PubMed  Google Scholar 

  5. Goffman TE, Laronga C, Wilson L (2004) Lymphedema of the arm and breast in irradiated breast cancer: risks in the era of dramatically changing axillary surgery. Breast J 10(5):405–411

    PubMed  Google Scholar 

  6. Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomized phase 3 trial. Lancet Oncol 11(10):927–933

    PubMed  PubMed Central  Google Scholar 

  7. Veronesi U, Viale G, Paganelli G et al (2010) Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 251(4):595–600

    PubMed  Google Scholar 

  8. Goyal A, Newcombe RG, Chhabra A (2006) Factors affecting failed localization and false-negative rates of sentinel node biopsy in breast cancer—results of the ALMANAC validation phase. Breast Cancer Res Treat 99(2):203–208

    PubMed  Google Scholar 

  9. Lyman GH, Temin S, Edge SB et al (2014) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 32(13):1365–1383

    PubMed  Google Scholar 

  10. Schwartz GF, Giuliano AE, Veronesi U et al (2002) Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer 94(10):2542–2551

    PubMed  Google Scholar 

  11. Silverstein MJ, Lagios MD, Recht A et al (2005) Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg 201(4):586–597

    PubMed  Google Scholar 

  12. Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77–84

    CAS  PubMed  Google Scholar 

  13. Herrinton LJ, Barlow WE, Yu O et al (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23(19):4275–4286

    PubMed  Google Scholar 

  14. Dupont EL, Kuhn MA, McCann C et al (2000) The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 180(4):274–277

    CAS  PubMed  Google Scholar 

  15. Veronesi U, Galimberti V, Zurrida S et al (2001) Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 37(4):454–458

    CAS  PubMed  Google Scholar 

  16. Viale G, Zurrida S, Mairoano E et al (2005) Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103(3):492–500

    PubMed  Google Scholar 

  17. Cox CE, Pendas S, Cox JM et al (1998) Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645–653

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Heuts EM, van der Ent FW, Kengen RA et al (2006) Results of sentinel node biopsy not affected by previous excisional biopsy. Eur J Surg Oncol 32(3):278–281

    CAS  PubMed  Google Scholar 

  19. Dinan D, Cagle CE, Pettinga J (2005) Lymphatic mapping and sentinel node biopsy in women with an ipsilateral second breast carcinoma and a history of breast and axillary surgery. Am J Surg 190(4):614–617

    PubMed  Google Scholar 

  20. Luini A, Galimberti V, Gatti G et al (2005) The sentinel lymph node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Technology. Breast Cancer Res Treat 89(2):159–163

    PubMed  Google Scholar 

  21. Intra M, Trifiro G, Viale G et al (2005) Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol 12(11):895–899

    PubMed  Google Scholar 

  22. Veronesi P, Intra M, Vento AR et al (2005) Sentinel lymph node biopsy for localized ductal carcinoma in situ? Breast 14(6):520–522

    CAS  PubMed  Google Scholar 

  23. Kelly TA, Kim JA, Patrick R et al (2003) Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 186(4):368–370

    PubMed  Google Scholar 

  24. Cox CE, Nguyen K, Gray RJ et al (2001) Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67(6):513–519

    CAS  PubMed  Google Scholar 

  25. Yen TW, Hunt KK, Ross MI et al (2005) Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200(4):516–526

    PubMed  Google Scholar 

  26. Tousimis E, Van Zee KJ, Fey JV et al (2003) The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg 197(4):529–535

    PubMed  Google Scholar 

  27. Goyal A, Newcombe RG, Mansel RE et al (2004) Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol 30(5):475–479

    CAS  PubMed  Google Scholar 

  28. Gentilini O, Trifiro G, Soteldo J et al (2006) Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology. Eur J Surg Oncol 32(5):507–510

    CAS  PubMed  Google Scholar 

  29. Knauer M, Konstantinuik P, Haid A et al (2006) Multicentric breast cancer: a new indication for sentinel node biopsy—a multi-institutional validation study. J Clin Oncol 24(21):3374–3380

    PubMed  Google Scholar 

  30. Holwitt DM, Gillanders WE, Aft RL et al (2008) Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence. Am J Surg 196(4):562–565

    PubMed  PubMed Central  Google Scholar 

  31. Fearmonti RM, Batista LI, Meric-Bernstam F et al (2009) False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden. Breast J 15(6):645–648

    PubMed  PubMed Central  Google Scholar 

  32. Lo YF, Cheung YC, Hsueh S, Ho KC (2009) Feasibility of sentinel lymph node biopsy in multifocal/multicentric breast cancer. Chang Gung Med J 32(1):51–58

    PubMed  Google Scholar 

  33. Kumar R, Jana S, Heiba SI et al (2003) Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. J Nucl Med 44(1):7–10

    PubMed  Google Scholar 

  34. Bauer TW, Spitz FR, Callans LS et al (2002) Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 9:169–176

    PubMed  Google Scholar 

  35. Vetto J, Jun SY, Paduch D et al (1999) Stages at presentation, prognostic factors, and outcome of breast cancer in males. Am J Surg 177(5):379–383

    CAS  PubMed  Google Scholar 

  36. Port ER, Fey JV, Cody HS, Borgen PI (2001) Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer 91(2):319–323

    CAS  PubMed  Google Scholar 

  37. Giuliano AE, Hawes D, Ballman KV et al (2011) Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 306:385–393

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412–421

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Galimberti V, Cole BF, Zurrida S et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14:297–305

    PubMed  PubMed Central  Google Scholar 

  41. Fisher B, Wolmark N, Banes M (1981) The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Gynecol Obstet 152:765–772

    CAS  Google Scholar 

  42. De Freitas R Jr, Costa MV, Schneider SV et al (1991) Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 17:240–244

    PubMed  Google Scholar 

  43. Vaidya JS, Vyas JJ, Thakur MH et al (1996) Role of ultrasound to detect axillary node involvement in operable breast cancer. Eur J Surg Oncol 22:140–143

    CAS  PubMed  Google Scholar 

  44. Specht MC, Fey JV, Borgen PI et al (2005) Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg 200:10–14

    PubMed  Google Scholar 

  45. Hunt KK, Yi M, Mittendorf MA et al (2009) Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 250(4):558–566

    PubMed  Google Scholar 

  46. Van Deurzen CH, Vriens BE, Tjan-Heijnen VC et al (2009) Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 45(18):3124–3130

    PubMed  Google Scholar 

  47. Xing Y, Foy M, Cox DD et al (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93(5):539–546

    CAS  PubMed  Google Scholar 

  48. Tausch C, Konstantiniuk P, Kugler F et al (2008) Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol 15(12):3378–3383

    PubMed  Google Scholar 

  49. Menard JP, Extra JM, Jacquemier J et al (2009) Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy. Eur J Surg Oncol 35(9):916–920

    PubMed  Google Scholar 

  50. Schwartz GF, Tannebaum JE, Jernigan AM et al (2010) Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast. Cancer 116(5):1243–1251

    PubMed  Google Scholar 

  51. Pecha V, Kolarik D, Kozevnikova R et al (2011) Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Cancer 117(20):4606–4616

    PubMed  Google Scholar 

  52. Aguiar PH, Pinheiro LG, Mota RM et al (2012) Sentinel lymph node biopsy in patients with locally advanced breast cancer after neoadjuvant chemotherapy. Acta Cir Bras 27(12):912–916

    PubMed  Google Scholar 

  53. Zhang GC, Liao N, Guo ZB et al (2013) Accuracy and axilla sparing potentials of sentinel lymph node biopsy with methylene blue alone performed before versus after neoadjuvant chemotherapy in breast cancer: a single institution experience. Clin Transl Oncol 15(1):79–84

    CAS  PubMed  Google Scholar 

  54. Mamounas EP, Brown A, Anderson S et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23(12):2694–2702

    PubMed  Google Scholar 

  55. Vlastos G, Mirza NQ, Lenert JT et al (2000) The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. Cancer 88(6):1417–1424

    CAS  PubMed  Google Scholar 

  56. Cance WG, Carey LA, Calvo BF et al (2002) Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 236(3):295–302

    PubMed  PubMed Central  Google Scholar 

  57. Alvarado R, Yi M, Le-Petross H et al (2012) The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 19(10):3177–3184

    PubMed  Google Scholar 

  58. Gimbergues P, Abrial C, Durando X et al (2008) Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 15(5):1316–1321

    CAS  PubMed  Google Scholar 

  59. Wolmark N, Wang J, Mamounas E et al (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr (30):96–102

    Google Scholar 

  60. Dominici LS, Negron Gonzalez VM, Buzdar AU et al (2010) Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer 116(12):2884–2889

    PubMed  PubMed Central  Google Scholar 

  61. Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (alliance) clinical trial. JAMA 310(14):1455–1461

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Boughey JC, Suman VJ, Mittendorf EA et al (2015) Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (alliance). Ann Surg 261(3):547–552

    PubMed  PubMed Central  Google Scholar 

  63. Kuehn T, Bauerfeind I, Fehm T et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14(7):609–618

    PubMed  Google Scholar 

  64. Agarwal A, Heron DE, Sumkin J, Falk J (2005) Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer. J Surg Oncol 92(1):4–8

    PubMed  Google Scholar 

  65. Port ER, Fey J, Gemignani ML et al (2002) Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 195(2):167–172

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Farin Amersi & Armando E. Giuliano

Authors
  1. Farin Amersi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Armando E. Giuliano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Armando E. Giuliano .

Editor information

Editors and Affiliations

  1. Our Lady of Grace Hospital, Positivo University, Curitiba, Brazil

    Cicero Urban

  2. Plastic and Reconstructive Division, European Institute of Oncology, Milan, Italy

    Mario Rietjens

  3. Memorial Sloan Kettering Cancer Center, New York, USA

    Mahmoud El-Tamer

  4. Memorial Sloan Kettering Cancer Center, New York, USA

    Virgilio S. Sacchini

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Amersi, F., Giuliano, A.E. (2019). Axillary Surgery. In: Urban, C., Rietjens, M., El-Tamer, M., Sacchini, V.S. (eds) Oncoplastic and Reconstructive Breast Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-62927-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62927-8_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62925-4

  • Online ISBN: 978-3-319-62927-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation